We are excited to reach this important milestone in the Expander-2 Pivotal Trial,” said Paul Edwards, President and CEO of Prodeon Medical. “Completing enrollment is a key step in our mission to ...
GREENBRAE, Calif.--(BUSINESS WIRE)--MarinHealth Medical Center (MHMC) announced today that its surgeons have performed the first Aquablation procedures to treat benign prostatic hyperplasia (BPH).
Both Original Medicare and Medicare Advantage cover Rezum water vapor therapy for lower urinary tract symptoms related to benign prostatic hyperplasia (also known as an enlarged prostate). However, ...